Toronto-Dominion Bank »

Liminatus Pharma shares owned by Toronto-Dominion Bank

Quarter-by-quarter ownership of Liminatus Pharma (LIMNW) shares owned by Toronto-Dominion Bank from 13F filings

Historical chart of Toronto-Dominion Bank investment in Liminatus Pharma

Tip: Access up to 7 years of quarterly data

All positions including Liminatus Pharma held by Toronto-Dominion Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Liminatus Pharma by Toronto-Dominion Bank

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.2k 35k 0.15
2025-06-30 $8.4k 35k 0.24

More positions owned by Toronto-Dominion Bank

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Rbc Cad (RY)
Cibc Cad (CM)
Tesla Motors (TSLA)
Amazon (AMZN)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Canadian Natural Resources (CNQ)
Spdr Gold Tr Gold Shs (GLD)
Bank Of Montreal Cadcom (BMO)
Meta Platforms Cl A (META)
Tc Energy Corp (TRP)
UnitedHealth (UNH)

View all positions for Toronto-Dominion Bank

Top funds holding Liminatus Pharma

Clear Street
Aristeia Capital
Linden Advisors
Saba Capital Management
Highbridge Capital Management
Moore Capital Management
Polar Securities
MMCAP International Inc. SPC
Nomura Holdings
Falcon Edge Capital
D. E. Shaw & Co
Millennium Management
Wolverine Asset Management
Blue Owl Capital Holdings
Periscope Capital

View all funds holding Liminatus Pharma